0001140361-15-001642.txt : 20150113
0001140361-15-001642.hdr.sgml : 20150113
20150113172613
ACCESSION NUMBER: 0001140361-15-001642
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150113
DATE AS OF CHANGE: 20150113
EFFECTIVENESS DATE: 20150113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioRestorative Therapies, Inc.
CENTRAL INDEX KEY: 0001505497
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 911835664
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-213985
FILM NUMBER: 15525542
BUSINESS ADDRESS:
STREET 1: 555 HERITAGE DRIVE
STREET 2: SUITE 130
CITY: JUPITER
STATE: FL
ZIP: 33458
BUSINESS PHONE: 561-904-6070
MAIL ADDRESS:
STREET 1: 555 HERITAGE DRIVE
STREET 2: SUITE 130
CITY: JUPITER
STATE: FL
ZIP: 33458
FORMER COMPANY:
FORMER CONFORMED NAME: Stem Cell Assurance, Inc.
DATE OF NAME CHANGE: 20101110
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001505497
BioRestorative Therapies, Inc.
40 Marcus Drive
SUITE ONE
MELVILLE
NY
NEW YORK
11747
631-760-8100
NEVADA
Traxxec Inc.
Stem Cell Assurance, Inc.
Corporation
true
Mark
Weinreb
c/o 40 Marcus Drive
Suite One
Melville
NY
NEW YORK
11747
Executive Officer
Director
Chief Executive Officer, Chairman of the Board and President
A.
Jeffrey
Radov
8 Walworth Avenue
Scarsdale
NY
NEW YORK
10583
Director
Mandy
Clyde
c/o 40 Marcus Drive
Suite One
Melville
NY
NEW YORK
11747
Executive Officer
Vice President of Operations and Secretary
Francisco
Silva
c/o 40 Marcus Drive
Suite One
Melville
NY
NEW YORK
11747
Executive Officer
Vice President of Research and Development and Assistant Secretary
Paul
Jude
Tonna
69 Chichester Road
Huntington
NY
NEW YORK
11743
Director
Joseph
B.
Swiader
6 Baldwin Road
Middletown
RI
RHODE ISLAND
02842
Director
Biotechnology
$1 - $1,000,000
- 06b
true
0001140361-14-013696
2014-01-14
true
true
true
true
false
0
Indefinite
4300000
Indefinite
false
52
0
0
1200000
true
false
BioRestorative Therapies, Inc.
/s/ Mark Weinreb
Mark Weinreb
Chief Executive Officer
2015-01-13